Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CHEK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
IER5L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
L3MBTL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUP62 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SSBP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GNPDA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CTSO - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELAC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NBEAL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRKAG2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SIN3B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PI4KB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AMPD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IDH3G - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
REXO2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VPS53 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRRC2C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CXXC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NDUFS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on